Enhanced humoral immunity in mice lacking CB1 and CB2 receptors (Cnr1-/-/Cnr2-/- mice) is not due to increased splenic noradrenergic neuronal activity
- PMID: 24870806
- DOI: 10.1007/s11481-014-9549-x
Enhanced humoral immunity in mice lacking CB1 and CB2 receptors (Cnr1-/-/Cnr2-/- mice) is not due to increased splenic noradrenergic neuronal activity
Abstract
Peripheral sympathetic noradrenergic neurons originating in the celiac mesenteric plexus have axons that terminate in close proximity to antibody-producing B cells in the spleen. Norepinephrine (NE) released from these neurons is reported to augment antibody production in response to an immune challenge via an action at the β2-adrenergic receptor (β2AR). Cannabinoids are immunosuppressive, and mice lacking CB1 and CB2 receptors (Cnr1(-/-)/Cnr2(-/-) mice) have augmented cell-mediated immune responses. The purpose of this study was to determine if Cnr1(-/-)/Cnr2(-/-) mice also exhibit enhanced humoral immunity and if that is associated with corresponding changes in noradrenergic neurons terminating in the spleen. The results reveal that IgM and IgG are enhanced in Cnr1(-/-)/Cnr2(-/-) mice as compared to WT both in immunologically naïve and lipopolysaccharide (LPS)-treated mice. While the elevated antibody production was correlated with increased expression of β2AR on splenic B cells and increased splenic capsule NE concentrations, the activity of noradrenergic neurons was suppressed in spleens from Cnr1(-/-)/Cnr2(-/-) mice as compared with WT controls. Together, these results suggest that Cnr1(-/-)/Cnr2(-/-) mice exhibit enhanced NE vesicular storage in axon terminals in these neurons, which might limit the NE available to bind β2AR on target cells, such as B cells. The results also demonstrate that enhanced antibody responses in the absence of CB1 and CB2 receptors are not due to increased sympathetic noradrenergic neuronal activity in the spleen.
Similar articles
-
Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors.J Neuroimmune Pharmacol. 2016 Dec;11(4):669-679. doi: 10.1007/s11481-016-9689-2. Epub 2016 Jun 10. J Neuroimmune Pharmacol. 2016. PMID: 27287619
-
Combined deficiency of the Cnr1 and Cnr2 receptors protects against age-related bone loss by osteoclast inhibition.Aging Cell. 2017 Oct;16(5):1051-1061. doi: 10.1111/acel.12638. Epub 2017 Jul 28. Aging Cell. 2017. PMID: 28752643 Free PMC article.
-
Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.J Leukoc Biol. 2008 Dec;84(6):1574-84. doi: 10.1189/jlb.0508282. Epub 2008 Sep 12. J Leukoc Biol. 2008. PMID: 18791168 Free PMC article.
-
Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.Ann N Y Acad Sci. 2006 Aug;1074:514-36. doi: 10.1196/annals.1369.052. Ann N Y Acad Sci. 2006. PMID: 17105950 Review.
-
Cannabinoids and the skeleton: from marijuana to reversal of bone loss.Ann Med. 2009;41(8):560-7. doi: 10.1080/07853890903121025. Ann Med. 2009. PMID: 19634029 Review.
Cited by
-
Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder.Neuropsychopharmacology. 2018 Jan;43(1):80-102. doi: 10.1038/npp.2017.162. Epub 2017 Jul 26. Neuropsychopharmacology. 2018. PMID: 28745306 Free PMC article. Review.
-
Marijuana-Derived Cannabinoids Trigger a CB2/PI3K Axis of Suppression of the Innate Response to Oral Pathogens.Front Immunol. 2019 Oct 15;10:2288. doi: 10.3389/fimmu.2019.02288. eCollection 2019. Front Immunol. 2019. PMID: 31681262 Free PMC article.
-
Bidirectional Role of β2-Adrenergic Receptor in Autoimmune Diseases.Front Pharmacol. 2018 Nov 27;9:1313. doi: 10.3389/fphar.2018.01313. eCollection 2018. Front Pharmacol. 2018. PMID: 30538630 Free PMC article. Review.
-
Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors.J Neuroimmune Pharmacol. 2016 Dec;11(4):669-679. doi: 10.1007/s11481-016-9689-2. Epub 2016 Jun 10. J Neuroimmune Pharmacol. 2016. PMID: 27287619
-
Role of adrenergic receptor signalling in neuroimmune communication.Curr Res Immunol. 2021 Nov 25;2:202-217. doi: 10.1016/j.crimmu.2021.11.001. eCollection 2021. Curr Res Immunol. 2021. PMID: 35492402 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources